Delivery Order SPE2DB22D2214-SPE2DB25FS4RD

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,338.94, is for the procurement of Chloraseptic Max 15-10 mg lozenges. The contract is a firm fixed-price delivery order, with a period of performance through January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,533.11, is for the delivery of Chloraseptic Sore 18s, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period extending through May 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.34, is a Firm Fixed Price Delivery Order for the procurement of CHLORASEPTIC MAX 15-10 MG LOZ 15S medical products. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,156.09 firm fixed-price delivery order is for the supply of Chloraseptic Max 15-10 mg lozenges to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency awarded a $12,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count bottles of Chloraseptic sore throat lozenges. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order runs from August 15 through August 16, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill this order for sore throat medication to support Defense...
The Defense Logistics Agency awarded a $58,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561556611 Chloraseptic sore throat lozenges. The single day order is to be fulfilled on July 20-21, 2023 with performance taking place in Conshohocken, Pennsylvania. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested over-the-counter medication to support the Defense Logistics Agency's stockpile needs. No additional...
The Defense Logistics Agency awarded a $84 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count packages of Chloraseptic sore throat lozenges. As the prime contractor, Amerisourcebergen will deliver the lozenges to a location in Conshohocken, Pennsylvania under a one day period of performance from July 10-11, 2023. The Defense Logistics Agency commonly issues delivery orders against various indefinite-delivery/indefinite-quantity multiple award contracts to...
This federal contract award is a delivery order with a firm fixed price valued at $1,457.47, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4566405605 - CHLORASEPTIC MAX 15-10 MG LOZ 15S, with a period of performance through November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The Defense Logistics Agency awarded a $375,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18,000 boxes of Chloraseptic sore throat lozenges. As part of its mission to provide logistics support to the Department of Defense, the Defense Logistics Agency issued this delivery order under an indefinite-delivery/indefinite-quantity contract vehicle to supply medical products to military treatment facilities. Amerisourcebergen will fulfill the order from its facility...
The Defense Logistics Agency awarded a $158 delivery order to Amerisourcebergen Drug Corporation for Cepacol sore throat lozenges. As the prime contractor, Amerisourcebergen will supply approximately 16,000 lozenges to a Defense Logistics Agency facility in Conshohocken, Pennsylvania over a one-day period in September 2023. The firm fixed price order was awarded under an existing Amerisourcebergen indefinite delivery/indefinite quantity contract vehicle and no subcontractors or set aside...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS4RD
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,111.64, is for the supply of 4,567,926,337 units of Chloraseptic sore throat lozenges. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract, indicating open competition.

Generated 7/15/25, 4:04 PM